125 related articles for article (PubMed ID: 11988079)
21. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
[TBL] [Abstract][Full Text] [Related]
22. Rapid acquisition of beta-sheet structure in the prion protein prior to multimer formation.
Post K; Pitschke M; Schäfer O; Wille H; Appel TR; Kirsch D; Mehlhorn I; Serban H; Prusiner SB; Riesner D
Biol Chem; 1998 Nov; 379(11):1307-17. PubMed ID: 9865603
[TBL] [Abstract][Full Text] [Related]
23. Formation of critical oligomers is a key event during conformational transition of recombinant syrian hamster prion protein.
Sokolowski F; Modler AJ; Masuch R; Zirwer D; Baier M; Lutsch G; Moss DA; Gast K; Naumann D
J Biol Chem; 2003 Oct; 278(42):40481-92. PubMed ID: 12917432
[TBL] [Abstract][Full Text] [Related]
24. Limited proteolysis of bovine alpha-lactalbumin: isolation and characterization of protein domains.
Polverino de Laureto P; Scaramella E; Frigo M; Wondrich FG; De Filippis V; Zambonin M; Fontana A
Protein Sci; 1999 Nov; 8(11):2290-303. PubMed ID: 10595532
[TBL] [Abstract][Full Text] [Related]
25. Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein.
Cereghetti GM; Schweiger A; Glockshuber R; Van Doorslaer S
Biophys J; 2001 Jul; 81(1):516-25. PubMed ID: 11423433
[TBL] [Abstract][Full Text] [Related]
26. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
27. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry.
Sajnani G; Pastrana MA; Dynin I; Onisko B; Requena JR
J Mol Biol; 2008 Sep; 382(1):88-98. PubMed ID: 18621059
[TBL] [Abstract][Full Text] [Related]
28. Slow spontaneous α-to-β structural conversion in a non-denaturing neutral condition reveals the intrinsically disordered property of the disulfide-reduced recombinant mouse prion protein.
Sang JC; Lee CY; Luh FY; Huang YW; Chiang YW; Chen RP
Prion; 2012; 6(5):489-97. PubMed ID: 22987112
[TBL] [Abstract][Full Text] [Related]
29. Copper(II) inhibits in vitro conformational conversion of ovine prion protein triggered by low pH.
Liu ML; Li YX; Zhou XM; Zhao DM
J Biochem; 2008 Mar; 143(3):333-7. PubMed ID: 18039688
[TBL] [Abstract][Full Text] [Related]
30. Copper refolding of prion protein.
Wong BS; Vénien-Bryan C; Williamson RA; Burton DR; Gambetti P; Sy MS; Brown DR; Jones IM
Biochem Biophys Res Commun; 2000 Oct; 276(3):1217-24. PubMed ID: 11027613
[TBL] [Abstract][Full Text] [Related]
31. Assembly of the full-length recombinant mouse prion protein I. Formation of soluble oligomers.
Vendrely C; Valadié H; Bednarova L; Cardin L; Pasdeloup M; Cappadoro J; Bednar J; Rinaudo M; Jamin M
Biochim Biophys Acta; 2005 Aug; 1724(3):355-66. PubMed ID: 15975719
[TBL] [Abstract][Full Text] [Related]
32. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments.
Di Natale G; Pappalardo G; Milardi D; Sciacca MF; Attanasio F; La Mendola D; Rizzarelli E
J Phys Chem B; 2010 Nov; 114(43):13830-8. PubMed ID: 20936829
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of laminin chain assembly into a triple-stranded coiled-coil structure.
Nomizu M; Utani A; Beck K; Otaka A; Roller PP; Yamada Y
Biochemistry; 1996 Mar; 35(9):2885-93. PubMed ID: 8608125
[TBL] [Abstract][Full Text] [Related]
34. Post-translational hydroxylation at the N-terminus of the prion protein reveals presence of PPII structure in vivo.
Gill AC; Ritchie MA; Hunt LG; Steane SE; Davies KG; Bocking SP; Rhie AG; Bennett AD; Hope J
EMBO J; 2000 Oct; 19(20):5324-31. PubMed ID: 11032800
[TBL] [Abstract][Full Text] [Related]
35. Protein conformational changes determined by matrix-assisted laser desorption mass spectrometry.
Yang HH; Li XC; Amft M; Grotemeyer J
Anal Biochem; 1998 Apr; 258(1):118-26. PubMed ID: 9527857
[TBL] [Abstract][Full Text] [Related]
36. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
Satheeshkumar KS; Jayakumar R
Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
[TBL] [Abstract][Full Text] [Related]
37. The peculiar nature of unfolding of the human prion protein.
Baskakov IV; Legname G; Gryczynski Z; Prusiner SB
Protein Sci; 2004 Mar; 13(3):586-95. PubMed ID: 14767078
[TBL] [Abstract][Full Text] [Related]
38. Prion protein NMR structure from tammar wallaby (Macropus eugenii) shows that the beta2-alpha2 loop is modulated by long-range sequence effects.
Christen B; Hornemann S; Damberger FF; Wüthrich K
J Mol Biol; 2009 Jun; 389(5):833-45. PubMed ID: 19393664
[TBL] [Abstract][Full Text] [Related]
39. Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation.
Cappai R; Stewart L; Jobling MF; Thyer JM; White AR; Beyreuther K; Collins SJ; Masters CL; Barrow CJ
Biochemistry; 1999 Mar; 38(11):3280-4. PubMed ID: 10079070
[TBL] [Abstract][Full Text] [Related]
40. Production, purification and oxidative folding of the mouse recombinant prion protein.
Pavlícek A; Bednárová L; Holada K
Folia Microbiol (Praha); 2007; 52(4):391-7. PubMed ID: 18062188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
